DEF 14A

Company

Amphastar Pharmaceuticals, Inc.

Filed

April 14, 2021

Period of Report

June 7, 2021

Accession Number

0001297184-21-000015

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →